SMTL ID : 4hx5.2 (1 other biounit)

Crystal structure of 11 beta-HSD1 in complex with SAR184841

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

homo-tetramer

Ligands

4 x 19V: 4-[5-(4-tert-butylpiperazin-1-yl)pyridin-2-yl]-N-[(1R,2S,3S,5S,7s)-5-carbamoyltricyclo[3.3.1.1~3,7~]dec-2-yl]-3,4-dihydroquinoxaline-1(2H)-carboxamide(Non-covalent)

19V.1: 23 residues within 4Å: Chain A: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.221, M.227, D.253, S.255, T.258 Chain B: L.270, L.273, Y.274 Ligands: NDP.2 16 PLIP interactions: 13 interactions with chain A, 3 interactions with chain B Hydrophobic interactions: A:I.115, A:L.120, A:L.165, A:Y.171, A:Y.177, A:A.217, A:A.220, A:V.221, B:Y.274, B:Y.274, B:Y.274 Hydrogen bonds: A:S.164, A:Y.177, A:L.211 Salt bridges: A:D.253 pi-Stacking: A:Y.171 19V.3: 24 residues within 4Å: Chain A: L.273, Y.274, Y.278 Chain B: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.225, M.227, D.253, S.255, T.258 Ligands: NDP.4 15 PLIP interactions: 2 interactions with chain A, 13 interactions with chain B Hydrophobic interactions: A:L.273, B:I.115, B:T.118, B:L.120, B:Y.171, B:V.174, B:Y.177, B:Y.177, B:A.217, B:A.220, B:V.225 pi-Stacking: A:Y.274 Hydrogen bonds: B:S.164, B:L.211 Salt bridges: B:D.253 19V.5: 23 residues within 4Å: Chain C: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.221, V.225, M.227, D.253, S.255, T.258 Chain D: L.270, L.273 Ligands: NDP.6 12 PLIP interactions: 12 interactions with chain C Hydrophobic interactions: C:I.115, C:L.120, C:Y.171, C:Y.177, C:Y.177, C:A.217, C:A.220, C:V.221, C:V.225 Hydrogen bonds: C:T.118, C:S.164, C:L.211 19V.7: 24 residues within 4Å: Chain C: Y.274, S.277, Y.278 Chain D: I.115, T.118, L.120, S.164, A.166, Y.171, V.174, Y.177, L.209, G.210, L.211, T.216, A.217, A.220, V.221, V.225, M.227, Q.228, D.253, S.255 Ligands: NDP.8 15 PLIP interactions: 14 interactions with chain D, 1 interactions with chain C Hydrophobic interactions: D:I.115, D:T.118, D:L.120, D:L.120, D:V.174, D:Y.177, D:A.217, D:A.220, D:V.221, D:V.225, D:M.227 Hydrogen bonds: D:S.164, D:Y.177, D:L.211 pi-Stacking: C:Y.274

4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.2: 28 residues within 4Å: Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 19V.1 27 PLIP interactions: 27 interactions with chain A Hydrophobic interactions: A:L.209 Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:M.87, A:N.113, A:N.113, A:I.115, A:Y.141, A:K.181, A:I.212, A:T.214, A:T.214, A:T.216, A:T.216 Water bridges: A:K.38, A:G.41, A:R.60, A:S.61, A:S.61, A:T.214 Salt bridges: A:R.60 NDP.4: 29 residues within 4Å: Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 19V.3 34 PLIP interactions: 34 interactions with chain B Hydrophobic interactions: B:L.209 Hydrogen bonds: B:G.35, B:S.37, B:S.37, B:K.38, B:I.40, B:R.60, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:N.113, B:I.115, B:Y.141, B:Y.177, B:K.181, B:I.212, B:T.214, B:T.214, B:T.214, B:T.216, B:T.216 Water bridges: B:S.37, B:K.38, B:K.38, B:G.39, B:G.41, B:S.61, B:T.116, B:T.116 Salt bridges: B:K.38, B:R.60 NDP.6: 30 residues within 4Å: Chain B: L.73 Chain C: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 19V.5 27 PLIP interactions: 27 interactions with chain C Hydrophobic interactions: C:L.209 Hydrogen bonds: C:S.37, C:S.37, C:K.38, C:K.38, C:I.40, C:R.60, C:S.61, C:T.86, C:T.86, C:M.87, C:N.113, C:N.113, C:I.115, C:Y.141, C:Y.177, C:K.181, C:I.212, C:T.214, C:T.214, C:T.214, C:T.216 Water bridges: C:G.41, C:T.116, C:T.216 Salt bridges: C:K.38, C:R.60 NDP.8: 28 residues within 4Å: Chain D: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: 19V.7 24 PLIP interactions: 24 interactions with chain D Hydrophobic interactions: D:L.209 Hydrogen bonds: D:G.35, D:S.37, D:S.37, D:K.38, D:I.40, D:R.60, D:S.61, D:T.86, D:M.87, D:N.113, D:N.113, D:I.115, D:Y.141, D:K.181, D:I.212, D:I.212, D:T.214, D:T.216, D:T.216 Water bridges: D:G.41, D:T.214 Salt bridges: D:K.38, D:R.60

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Venier, O. et al., Discovery of SAR184841, a potent and long-lasting inhibitor of 11beta-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D. Bioorg.Med.Chem.Lett. (2013)

Release Date

2013-05-08

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence